|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/53 | |
| A61K 31/015 |
| (11) | Patento numeris | 2478362 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10817999.5 |
| Europos patento paraiškos padavimo data | 2010-09-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-07-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-05-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/049545 |
| Data | 2010-09-20 |
| (87) | Numeris | WO 2011/035274 |
| Data | 2011-03-24 |
| (30) | Numeris | Data | Šalis |
| 276969 P | 2009-09-18 | US |
| (72) |
TRIEU, Vuong, US
DESAI, Neil, US
|
| (73) |
Abraxis BioScience, LLC,
11755 Wilshire Boulevard, Los Angeles, CA 90025,
US
|
| (54) | USE OF THE SPARC MICROENVIRONMENT SIGNATURE IN THE TREATMENT OF CANCER |
| USE OF THE SPARC MICROENVIRONMENT SIGNATURE IN THE TREATMENT OF CANCER |